Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
PMV Pharmaceuticals, Inc. PMVP
$5.68
+$0.04 (0.62%)
На 18:03, 12 мая 2023
+451.58%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
227043008.00000000
-
week52high
18.12
-
week52low
3.84
-
Revenue
0
-
P/E TTM
-3
-
Beta
0.87976000
-
EPS
-1.68000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 12:30
Описание компании
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Oppenheimer | Outperform | Outperform | 09 июн 2022 г. |
| Goldman Sachs | Buy | Buy | 24 мая 2022 г. |
| Oppenheimer | Outperform | Perform | 02 мар 2022 г. |
| Goldman Sachs | Buy | Neutral | 22 сент 2021 г. |
| Oppenheimer | Perform | 19 авг 2021 г. | |
| HC Wainwright & Co. | Buy | Buy | 17 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Kung Winston | D | 10600 | 2560 | 25 ноя 2022 г. |
| Gallagher Carol Giltner | A | 39000 | 39000 | 05 ноя 2022 г. |
| Gallagher Carol Giltner | A | 39000 | 39000 | 04 ноя 2022 г. |
| Jalota Deepika | A | 34050 | 34050 | 09 сент 2022 г. |
| Alland Leila | A | 52200 | 52200 | 09 сент 2022 г. |
| Stelzer Laurie | D | 19500 | 19500 | 02 июн 2022 г. |
| LEVINE ARNOLD J | A | 19500 | 19500 | 02 июн 2022 г. |
| Heyman Richard A. | A | 19500 | 19500 | 02 июн 2022 г. |
| FLOWERS KIRSTEN | A | 19500 | 19500 | 02 июн 2022 г. |
| BAUM CHARLES M | A | 19500 | 19500 | 02 июн 2022 г. |
Новостная лента
Top 10 most-shorted stocks as of November 2022
Finbold
30 ноя 2022 г. в 11:18
The difficult state of the macroeconomic environment in 2022 has had a negative impact on the performance of a number of equity investments. Worries about a recession and a bearish attitude among investors have been especially unsettling for companies with weak financial positions.
PMV Pharmaceuticals, Inc. (PMVP) Upgraded to Buy: Here's What You Should Know
Zacks Investment Research
11 окт 2022 г. в 13:32
PMV Pharmaceuticals, Inc. (PMVP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
PMV Pharmaceuticals to Participate in the Goldman Sachs Global Healthcare Conference
GlobeNewsWire
08 июн 2022 г. в 08:00
CRANBURY, N.J., June 08, 2022 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP; “PMV Pharma”), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that David H. Mack, Ph.D., President & Chief Executive Officer of PMV Pharmaceuticals, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference taking place in Ranchos Palos Verdes, California June 14-16, 2022.
Halted Stocks: 9 Circuit Breaker Stocks That Have Been Halted on Tuesday
InvestorPlace
07 июн 2022 г. в 13:00
We've seen a large array of halted stocks today as circuit breakers take effect to reign in unexpected volatility for some shares. The post Halted Stocks: 9 Circuit Breaker Stocks That Have Been Halted on Tuesday appeared first on InvestorPlace.